UPDATE 1-Shire urges AbbVie to stick to original deal plan

LONDON, Oct 15 (Reuters) - London-listed pharmaceutical firm Shire plc said it believed U.S. suitor AbbVie should proceed with its $55 billion takeover despite a change to U.S. regulations which curbed the tax benefits of the tie-up.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.